Thoratec scooped up by St. Jude for $3.5bn
St. Jude Medical Inc. paid $3.5bn or $63.50 per share (a 34% premium) for fellow public cardiovascular-focused device firm Thoratec Corp.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.